Dr Helen McBreen is Investment Director at Atlantic Bridge Capital. Having successfully sourced, formed and financed dozens of IP rich technology ventures and with a credible investment track record Helen brings her expertise in early stage investing to Atlantic Bridge Capital.
Prior to joining Atlantic Bridge Capital, Helen was a member of the NDRC Investment Committee playing a key role in the allocation of €45m capital into new technology ventures with a particular focus on ventures in energy, health and ICT.
Helen holds a number of Board Member and Advisory positions including: eHealth Ireland, HealthXL Platform, UCD MSc Innovation, Entrepreneurship and Design, Enterprise Ireland Business Advisor in International Selling, UCD VentureLaunch and is a mentor to a number of tech startups.
Helen also held the position of Sales Director at Celtrak Ltd (acquired by Thermo King, 2015). She understands sales intimately, and in her role as Business Advisor to Enterprise Ireland client companies she works with growth stage companies to help them overcome expansion challenges in international markets.
Having earned a first class honours electronic engineering degree from UCD and a PhD from The University of Edinburgh, Helen is technical at heart and is particularly interested in technologies based on AI, robotics, big data & data science, bioinfomatics, medtech, neuroscience, connected health and nanotech.
In 2014, Helen successful initiated and implemented ‘FutureHealth’ in partnership with EY, ICON, UCD and Enterprise Ireland, with the objective of finding ten new healthtech startups from across Ireland.
Finally, Helen received peer recognition when she was listed as one of the Top 100 Women in STEM in Ireland